Contrasting responses of non-small cell lung cancer to antiangiogenic therapies depend on histological subtype. [electronic resource]
Producer: 20141205Description: 539-50 p. digitalISSN:- 1757-4684
- Angiogenesis Inhibitors -- administration & dosage
- Animals
- Antibodies, Monoclonal -- administration & dosage
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Female
- Humans
- Indoles -- administration & dosage
- Mice
- Mice, Inbred BALB C
- Pyrroles -- administration & dosage
- Sunitinib
- Treatment Outcome
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.